Altria Group Inc vs Health Care Select Sector SPDR Fund — how do they compare? Altria Group Inc trades at $73.24 (market cap $124.67B), while Health Care Select Sector SPDR Fund trades at $160.31. The key difference: Altria Group Inc pays a 5.68% dividend while Health Care Select Sector SPDR Fund pays none. Which is the better fit depends on your goals.
| MO | XLV | |
|---|---|---|
Market Cap | $124.67B | — |
Sector | Consumer Staples | — |
52-Week High | $74.66 | $164.48 |
52-Week Low | $54.72 | $129.01 |
Enterprise Value | $145.75B | — |
Dividend Yield | 5.68% | — |
Signals from Pluang's Aura AI — not financial advice
Altria Group (MO) trades at $72.99, down 1.64% on the day, with a P/E of 15.59 and strong net income margin of 39.52%. Recent earnings show mixed results, beating estimates in Q1 2026 but missing in Q4 2025. Technical indicators suggest a bullish trend with support at $73 and resistance at $75. The company maintains robust cash flow from operations at $9.29B and declared a $1.06 dividend payable in July 2026.
MO offers a high dividend yield and stable cash flows, appealing for income investors, but faces risks from declining smoking trends and regulatory pressures. Analyst consensus is bullish with a $71 price target, though revenue stagnation and debt levels warrant caution. The stock's defensive qualities provide stability amid market volatility.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Altria comprises Philip Morris USA, U.S. Smokeless Tobacco, John Middleton, Helix Innovations, and Philip Morris Capital, although the company plans to wind down Philip Morris Capital by the end of 2022. It holds a 10% interest in the world's largest brewer, Anheuser-Busch InBev. Through its tobacco subsidiaries, Altria holds the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the U.S. with a 43% share in 2020. Altria holds strategic investments in JUUL Labs (35% economic interest) and Cronos (42%).
Read more on MO →In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies from the following industries: pharmaceuticals; health care equipment & supplies; health care providers & services; biotechnology; life sciences tools & services; and health care technology. The fund is non-diversified.
Read more on XLV →